Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction
Yosuke Kawamura1, Hiroaki Yokoyama1, Kazutaka Kitayama1
1Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Insights
Complete atrioventricular block (CAVB) is a rare but serious complication following ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). CAVB independently predicts worse outcomes, particularly in anterior STEMI patients, highlighting its prognostic significance.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Complete atrioventricular block (CAVB) is a known complication of ST-segment elevation myocardial infarction (STEMI).
- The prognostic impact of CAVB in STEMI patients undergoing primary percutaneous coronary intervention (PCI) remains incompletely understood.
- Previous data on CAVB and STEMI outcomes were primarily from the thrombolytic era.
Purpose of the Study:
- To evaluate the clinical impact and prognostic significance of CAVB in STEMI patients treated with primary PCI.
- To compare outcomes between anterior and nonanterior STEMI patients with and without CAVB.
- To identify CAVB as an independent predictor of mortality and major adverse cardiocerebrovascular events (MACCE) in the primary PCI era.
Main Methods:
- A consecutive cohort of 1295 STEMI patients undergoing primary PCI within 24 hours of symptom onset was analyzed.
- Patients were stratified into anterior STEMI (n=640) and nonanterior STEMI (n=655) groups.
- Outcomes, including all-cause death and MACCE, were assessed over a median follow-up of 3.8 years. CAVB development was recorded.
Main Results:
- CAVB occurred in 6.3% of patients, with a significantly lower incidence in anterior STEMI (1.7%) versus nonanterior STEMI (10.7%).
- Anterior STEMI patients with CAVB exhibited markedly higher rates of all-cause death (82% vs. 20%) and MACCE (82% vs. 25%) compared to those without CAVB.
- While nonanterior STEMI patients with CAVB had increased all-cause mortality (30% vs. 18%), MACCE rates were similar to those without CAVB (24% vs. 19%).
- Multivariate analysis identified CAVB as an independent predictor of mortality and MACCE in anterior STEMI, but not in nonanterior STEMI.
Conclusions:
- Complete atrioventricular block is infrequent in anterior STEMI but carries a poor prognosis, even with modern primary PCI treatment.
- CAVB is an independent predictor of adverse outcomes in anterior STEMI patients undergoing primary PCI.
- The prognostic implications of CAVB differ based on infarct location in the primary PCI era.
Abstract:
Complete atrioventricular block (CAVB) is a common complication of ST-segment elevation myocardial infarction (STEMI). Although STEMI patients complicated with CAVB had a higher mortality in the thrombolytic era, little is known about the impact of CAVB on STEMI patients who underwent primary percutaneous coronary intervention (PCI). The study aimed at evaluating the clinical impact of CAVB on STEMI patients in the primary PCI era. We consecutively enrolled 1295 STEMI patients undergoing primary PCI within 24 hours from onset. Patients were divided into two groups according to the infarct location: anterior STEMI (n = 640) and nonanterior STEMI (n = 655). The outcomes were all-cause death and major adverse cardiocerebrovascular events (MACCE) with a median follow-up period of 3.8 (1.7-6.6) years. Eighty-one patients (6.3%) developed CAVB. The incidence of CAVB was lower in anterior STEMI patients than in nonanterior STEMI (1.7% vs 10.7%, p < .05). Anterior STEMI patients with CAVB had a higher incidence of all-cause deaths (82% vs 20%, p < .05) and MACCE (82% vs 25%, p < .05) than those without CAVB. Although higher incidence of all-cause deaths was found more in nonanterior STEMI patients with CAVB compared with those without CAVB (30% vs 18%, p < .05), there was no significant difference in the incidence of MACCE (24% vs 19%). Multivariate analysis showed that CAVB was an independent predictor for all-cause mortality and MACCE in anterior STEMI patients, but not in nonanterior STEMI. CAVB is rare in anterior STEMI patients, but remains a poor prognostic complication even in the primary PCI era.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Myocarditis I: Introduction


